Evidence map›Paper›PMID 32392815›Full record

ArticlePathogens (Basel, Switzerland)2020

Clinical Outcomes of a Zika Virus Mother-Child Pair Cohort in Spain.

Antoni Soriano-Arandes, Marie Antoinette Frick, Milagros García López-Hortelano, Elena Sulleiro, Carlota Rodó, María Paz Sánchez-Seco, Marta Cabrera-Lafuente, Anna Suy, María De la Calle, Mar Santos and 24 more

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 14 institutions in 3 countries.

Antoni Soriano-ArandesPaediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0001-9613-7228
Marie Antoinette FrickPaediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Milagros García López-HortelanoDepartment of Paediatrics, Hospital Universitario La Paz, 28046 Madrid, Spain.
Elena SulleiroDepartament of Microbiology, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
Carlota RodóUnit of Fetal Medicine, Department of Obstetrics, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.ORCID 0000-0001-8801-5677
María Paz Sánchez-SecoInstituto de Salud Carlos III, 28029 Madrid, Spain.
Marta Cabrera-LafuenteDepartment of Neonatology, Hospital Universitario La Paz, 28046 Madrid, Spain.
Anna SuyUnit of Fetal Medicine, Department of Obstetrics, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.ORCID 0000-0003-2987-6105
María De la CalleDepartment of Obstetrics, Hospital Universitario La Paz, 28046 Madrid, Spain.
Mar SantosDepartment of Paediatrics, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.
Eugenia AntolinDepartment of Obstetrics, Hospital Universitario La Paz, 28046 Madrid, Spain.
María Del Carmen ViñuelaDepartment of Obstetrics, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.
María EspiauPaediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0001-9697-7649
Ainara SalazarPaediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Borja Guarch-IbáñezDepartment of Paediatrics, Hospital Universitari Josep Trueta, 17007 Girona, Spain.
Ana VázquezInstituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-9872-3316
Juan Navarro-MorónHospital Costa del Sol, 29603 Marbella, Spain.
José-Tomás Ramos-AmadorDepartment of Paediatrics, Hospital Universitario Clínico San Carlos, 28040 Madrid, Spain.
Andrea Martin-NaldaPaediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Eva DueñasDepartment of Paediatrics, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.
Daniel Blázquez-GameroPediatric Infectious Diseases Unit, Hospital Universitario 12 de Octubre, Madrid, Instituto de Investigación Hospital 12 de Octubre (imas12), Universidad Complutense, 28041 Madrid, Spain.
Resurrección Reques-CosmeHospital El Escorial, 28200 Madrid, Spain.
Iciar OlabarrietaHospital Severo Ochoa, Leganés, 28911 Madrid, Spain.
Luis PrietoPediatric Infectious Diseases Unit, Hospital Universitario 12 de Octubre, Madrid, Instituto de Investigación Hospital 12 de Octubre (imas12), Universidad Complutense, 28041 Madrid, Spain.
Fernando De OryInstituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-6981-1261
Claire ThorneUniversity College London Great Ormond Street Institute of Child Health, GOSH NIHR BRC, London WC1N 1EH, UK.
Thomas ByrneUniversity College London Great Ormond Street Institute of Child Health, GOSH NIHR BRC, London WC1N 1EH, UK.
Anthony E AdesUniversity of Bristol, Bristol BS9 1AF, UK.
Elisa Ruiz-BurgaUniversity College London Great Ormond Street Institute of Child Health, GOSH NIHR BRC, London WC1N 1EH, UK.ORCID 0000-0002-0529-0372
Carlo GiaquintoDivision of Pediatric Infectious Diseases, Department for Woman and Child Health, University of Padova, 35122 Padova, Italy.
María José Mellado-PeñaDepartment of Paediatrics, Hospital Universitario La Paz, 28046 Madrid, Spain.
Alfredo García-AlixFundació NeNe, 28010 Madrid, Spain.ORCID 0000-0002-7972-8453
Elena CarrerasUnit of Fetal Medicine, Department of Obstetrics, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
Pere Soler-PalacínPaediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-0346-5570
Universitat Autònoma de Barcelona · ESHospital Universitario La Paz · ESVall d'Hebron Hospital Universitari · ESHospital General Universitario Gregorio Marañón · ESInstituto de Salud Carlos III · ESUniversity College London · GBResearch Institute Hospital 12 de Octubre · ESHospital Clínico San Carlos · ESHospital Costa del Sol · ESHospital El Escorial · ESHospital Universitari de Girona Doctor Josep Trueta · ESHospital Universitario Severo Ochoa · ESUniversity of Bristol · GBUniversity of Padua · IT

Funding

European Commission 734857Medical Research Council MC_U145079307
6 · The paper itself

Abstract

backgroundZika virus (ZIKV) infection has been associated with congenital microcephaly and other neurodevelopmental abnormalities. There is little published research on the effect of maternal ZIKV infection in a non-endemic European region. We aimed to describe the outcomes of pregnant travelers diagnosed as ZIKV-infected in Spain, and their exposed children.

methodsThis prospective observational cohort study of nine referral hospitals enrolled pregnant women (PW) who travelled to endemic areas during their pregnancy or the two previous months, or those whose sexual partners visited endemic areas in the previous 6 months. Infants of ZIKV-infected mothers were followed for about two years.

resultsZIKV infection was diagnosed in 163 PW; 112 (70%) were asymptomatic and 24 (14.7%) were confirmed cases. Among 143 infants, 14 (9.8%) had adverse outcomes during follow-up; three had a congenital Zika syndrome (CZS), and 11 other potential Zika-related outcomes. The overall incidence of CZS was 2.1% (95%CI: 0.4-6.0%), but among infants born to ZIKV-confirmed mothers, this increased to 15.8% (95%CI: 3.4-39.6%).

conclusionsA nearly 10% overall risk of neurologic and hearing adverse outcomes was found in ZIKV-exposed children born to a ZIKV-infected traveler PW. Longer-term follow-up of these children is needed to assess whether there are any later-onset manifestations.

Indexed as

adverse outcomearbovirusescongenital infectionmicrocephalyzika virus

Identifiers

PMID32392815
PMCPMC7281364
OpenAlexW3023486061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.